Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 3.42 -2.29% -0.08
ACHN closed down 2.29 percent on Thursday, April 27, 2017, on 54 percent of normal volume.

Earnings due: May 2

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ACHN trend table...

Date Alert Name Type % Chg
Apr 27 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Apr 26 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.29%
Apr 26 Calm After Storm Range Contraction -2.29%
Apr 25 Lower Bollinger Band Walk Other -1.72%
Apr 25 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.72%
Apr 25 Jack-in-the-Box Bearish Bearish Swing Setup -1.72%
Apr 24 New 52 Week Low Bearish 6.54%
Apr 24 Volume Surge Other 6.54%
Apr 24 Wide Range Bar Range Expansion 6.54%
Apr 24 Reversal New Lows Setup Bearish Swing Setup 6.54%

Older signals for ACHN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company’s drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.06
52 Week Low 3.15
Average Volume 1,461,231
200-Day Moving Average 5.7083
50-Day Moving Average 3.9206
20-Day Moving Average 3.708
10-Day Moving Average 3.531
Average True Range 0.1896
ADX 23.64
+DI 11.28
-DI: 24.06
Chandelier Exit (Long, 3 ATRs) 3.8812
Chandelier Exit (Short, 3 ATRs) 3.7188
Upper Bollinger Band 4.2085
Lower Bollinger Band 3.2075
Percent B (%b) 0.21
Bandwidth 0.269957